TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ABBV

AbbVie Inc

Healthcare · Drug Manufacturers - General

265.10$ +0.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

AbbVie Inc (ABBV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 3,436 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ABBV
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
1,454 1,541 2,102 2,003 3,271 2,584 2,645 2,866 4,524 3,392 3,017 2,477 4,555 3,275 3,815 3,089 5,830 4,854 4,877 4,890 7,935 5,075 4,908 5,005 7,602 7,428 4,193 6,319 7,574 4,753 4,040 2,271 5,447 7,048 1,635 5,153 7,024 5,218 3,829 3,436 19,507
304 328 374 379 379 369 445 443 435 442 503 502 503 509 559 1,555 2,292 2,065 2,215 2,200 2,127 1,979 2,053 2,052 2,205 2,157 2,127 2,260 2,235 2,076 2,074 2,131 2,079 2,102 2,039 2,050 2,063 1,987 1,936 1,883 7,869
69 75 141 76 71 77 191 85 75 70 189 87 75 79 219 236 162 136 269 159 135 129 306 107 126 132 313 179 130 125 348 218 181 674 410 179 209 157 444 166 976
503 313 299 251 297 1,052 245 1,142 530 4,760 520 2,540 1,407 287 332 2,124 260 3,673 63 2,914 920 135 -508 730 -4.0 2,428 2,500 1,318 918 – – – – – – – – – – – –
-951 -491 -282 -542 964 -131 -828 -702 812 -408 -462 -1,306 761 -322 -86 149 965 -922 -956 -990 1,708 -1,084 -1,275 -1,164 1,338 843 -825 552 2,643 443 247 -3,382 750 -397 -2,580 -562 3,142 -473 -1,922 -2,721 -1,974
113 114 95 126 126 182 119 114 282 123 107 128 154 163 125 177 217 279 188 195 217 187 162 143 177 213 175 178 219 205 193 241 249 291 235 269 504 329 265 265 1,363
-199 -119 -684 318 -109 201 -447 687 -963 -283 -27 -140 1,378 -615 -129 -35,652 -1,149 -627 -342 -242 -615 -1,145 -1,591 130 1,286 -448 -499 -341 -369 -800 -9,588 -1,102 -8,256 -1,874 -735 -1,181 -3,264 -1,463 -574 -1,197 -6,498
933 933 1,027 1,024 1,026 1,030 1,137 1,531 1,461 1,451 1,588 1,592 1,591 1,595 1,763 1,752 2,100 2,101 2,322 2,310 2,315 2,314 2,526 2,507 2,504 2,506 2,661 2,625 2,627 2,626 2,772 2,750 2,751 2,752 2,925 2,910 2,911 2,911 3,086 3,070 11,978
-6.0 -1,824 -895 -5.0 -5.0 -505 -1,431 -7,516 -1,009 -2,058 -620 -3.0 -4.0 -2.0 -643 -19 -20 -296 -787 -10 -6.0 -131 -1,470 -9.0 -4.0 -4.0 -1,955 -10 -4.0 -3.0 -1,324 -9.0 -17 -358 -961 -12 4.0 -3.0 -1,489 -9.0 -1,497
-495 212 17 -7.0 395 -408 -40 138 3,412 -321 -3,200 -368 1,150 28,241 -763 -783 -651 -1,269 -3,461 -3,461 -1,201 -3,752 -2,879 -2.0 -2,701 -6,851 -1,351 -1,002 -2.0 – – – -403 -3,762 2,561 209 -1,775 -1,299 5,492 -2,000 418
-1,371 -2,502 -1,794 -980 -810 -1,928 -2,509 -8,978 916 -3,825 -5,383 -2,070 -441 26,602 -2,422 -2,570 -2,814 -3,695 -3,174 -5,884 -3,643 -6,338 -6,972 -2,679 -5,518 -9,634 -6,192 -3,920 -2,661 -4,449 10,819 -6,097 -3,072 -6,861 -1,258 -2,710 -4,590 -4,166 919 -5,054 -12,891
-109 -1,118 -360 1,348 2,358 857 -296 -5,460 4,468 -726 -2,392 275 5,476 29,276 1,218 -35,125 1,873 559 1,306 -1,209 3,636 -2,436 -3,648 2,423 3,311 -2,631 -2,490 2,048 4,528 -473 5,253 -4,937 -5,873 -1,733 -349 1,292 -838 -400 4,162 -2,822 102
1,341 1,427 2,007 1,877 3,145 2,402 2,526 2,752 4,242 3,269 2,910 2,349 4,401 3,112 3,690 2,912 5,613 4,575 4,689 4,695 7,718 4,888 4,746 4,862 7,425 7,215 4,018 6,141 7,355 4,548 3,847 2,030 5,198 6,757 1,400 4,884 7,528 4,889 3,564 3,701 19,682

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?